Fierce Pharma
SEPTEMBER 14, 2023
While there's certainly more work to do, the U.S. | Efforts from regulators and manufacturers have brought the U.S. supply of cisplatin back to nearly 100% of pre-shortage levels, according to the White House. The moves are “greatly alleviating the shortages of carboplatin,” too, the White House said.
MedCity News
SEPTEMBER 14, 2023
This week, senators introduced a bipartisan bill that would make it a federal crime to assault hospital workers. Even though nearly 40 states have passed laws to intensify penalties for violent acts committed against healthcare personnel, there is currently no federal law protecting hospital employees from assault or intimidation.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Pharma
SEPTEMBER 14, 2023
Otsuka teamed up with Shape Therapeutics in an eye disease gene therapy deal potentially worth $1.5 billion. Astellas will build its third Irish manufacturing facility. | Otsuka teamed up with Shape Therapeutics in an eye disease gene therapy deal potentially worth $1.5 billion. Astellas will build its third Irish manufacturing facility for $354 million.
MedCity News
SEPTEMBER 14, 2023
By making large amounts of diverse data widely available, healthcare institutions can feel confident about the evaluation, creation, and validation of algorithms as they’re transitioned from ideation to use.
Advertiser: ZoomInfo
Marketing technology is essential for B2B marketers to stay competitive in a rapidly changing digital landscape — and with 53% of marketers experiencing legacy technology issues and limitations, they’re researching innovations to expand and refine their technology stacks. To help practitioners keep up with the rapidly evolving martech landscape, this special report will discuss: How practitioners are integrating technologies and systems to encourage information-sharing between departments and pr
Fierce Pharma
SEPTEMBER 14, 2023
Alongside a new logo reveal Thursday, Johnson & Johnson unveiled some major changes to its corporate persona. | J&J is uniting its medtech and pharmaceutical arms so that they will be “more connected to the Johnson & Johnson brand," the company said. Over time, Janssen is slated to become Johnson & Johnson Innovate Medicine, while the company’s medical technology segment will continue to run with the J&J MedTech moniker.
PharmExec
SEPTEMBER 14, 2023
Lung-I Cheng, vice president of cell and gene therapy (CGT), Cencora (formerly AmerisourceBergen), discusses CGT commercialization strategies, common knowledge gaps, and what he wishes companies knew about commercialization strategies.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
Eversana Intouch
SEPTEMBER 14, 2023
Digital medicine is emerging as a revolutionary field that can transform the entire spectrum of healthcare, from proactive prevention to effective treatment of diverse medical conditions. Unlike traditional pharmaceutical medications, digital medicine products need to speak to the clinical, economic and technological benefits to differentiate themselves from competitors.
Fierce Pharma
SEPTEMBER 14, 2023
Nearly seven years have passed since Alexion’s then-CEO and CFO stepped down amid an investigation into improper sales practices. | Alexion has reached a $125 million deal to settle a class action lawsuit brought by investors who lost money during a stock plunge caused by allegations about the company's sales practices for Soliris.
MedCity News
SEPTEMBER 14, 2023
MedImpact and GoodRx are teaming up to lower costs for MedImpact members. When eligible MedImpact members refill a generic prescription, the companies’ savings solution will compare the member’s benefit to GoodRx’s price and will automatically apply the lowest one.
Fierce Pharma
SEPTEMBER 14, 2023
By Dr Michael K Racke, Medical Director of Neurology, Quest Diagnostics | The escalating global challenge of Alzheimer's Disease (AD) demands new approaches to detection, diagnosis, and treatment. Dr. Racke will delve into recent advancements in the AD diagnostic landscape.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
European Pharmaceutical Review
SEPTEMBER 14, 2023
Under a new agreement, AstraZeneca is set to establish the first unsubsidised industrial-scale supply of biomethane. The pharmaceutical firm is investing greatly in its existing infrastructure to facilitate the shift to renewable gas and support a transition to 100 percent renewable energy. This includes its Macclesfield campus, the UK’s largest pharma manufacturing site.
Fierce Pharma
SEPTEMBER 14, 2023
A possible mutiny at Abcam?
European Pharmaceutical Review
SEPTEMBER 14, 2023
Rimegepant (Vydura) is the “first and only NICE-recommended medicine that can help alleviate the misery of acute migraines, and may be considered a step-change in treatment,” shared Helen Knight, Director of medicines evaluation at the National Institute for Health and Care Excellence (NICE). Made by Pfizer, Rimegepant (Vydura), is recommended in NICE final draft guidance for adults who have tried at least two triptans but failed to achieve adequate relief with these medicines.
PharmaTech
SEPTEMBER 14, 2023
The companies are collaborating to apply ShapeTX’s AAVid capsid discovery platform and transgene engineering technology in addition to Otsuka’s expertise in genetic payload design and ophthalmology to develop novel treatment options for eye diseases.
Advertiser: ZoomInfo
In times of economic uncertainty, account-based strategies are essential. According to several business analysts and practitioners, ABM is a necessity for creating more predictable revenue. Research shows that nearly three-quarters of marketers (74%) already have the resources needed to build successful ABM programs.
Medgadget
SEPTEMBER 14, 2023
Researchers at the Harvard Wyss Institute have developed a technique that lets clinicians to characterize and monitor melanoma. The system involves using a microneedle patch that can draw deep interstitial fluid into itself through a series of penetrating hyaluronic acid needles. The needles can later be dissolved to release the biomarkers into a test tube before analysis, using a highly sensitive technique called Simoa, to detect individual biomarker protein molecules.
MedCity News
SEPTEMBER 14, 2023
When Medicaid expansion was first enacted, it was a hot topic debate between Democrats and Republicans. But more and more states are starting to expand Medicaid, including several conservative states.
Medgadget
SEPTEMBER 14, 2023
Researchers at the University of California San Francisco have developed a brain computer interface that can lets someone with severe paralysis communicate with both speech and facial expressions, in the form of a digital avatar. The breakthrough advances what has been possible, with previous brain computer interface systems providing speech only, and allows people to communicate more completely, encompassing facial expressions, which are an important aspect of natural communication.
MedCity News
SEPTEMBER 14, 2023
Allogeneic cell therapy hasn’t caught up to autologous cell therapy yet, and the disappointing data so far has soured the entire allogeneic field for at least one venture capitalist. The cell therapy debate was one of the topics covered during a panel discussion at the Biopharm America conference.
Advertiser: ZoomInfo
Shifting to an account-based marketing (ABM) strategy can be both exciting and challenging. Well-implemented ABM motions build engagement with high-value accounts and drive impactful campaigns that resonate with your audience. But where do you begin, and how do you progress from crawling to running? Watch now as Demand Gen experts delve into the essentials of each stage of the ABM process.
European Pharmaceutical Review
SEPTEMBER 14, 2023
While the pharmaceutical industry has long been considered recession-proof—with a constant demand for medicines and new treatment options, today, the industry is facing several major challenges. For both small biotechs and large pharma, economic uncertainty is rising, intensifying decision-making risks associated with early drug discovery efforts, clinical trials, quality and manufacturing process execution, and navigating the approval process.
MedCity News
SEPTEMBER 14, 2023
Even though providers and payers don’t always get along, they need to come together now more than ever. In the post-pandemic landscape, the healthcare industry won’t be able to maintain care quality and protect patient access without strong collaboration between these two parties, health system leaders said during a virtual panel.
Medgadget
SEPTEMBER 14, 2023
Researchers at the National University of Singapore have developed a highly sensitive pressure sensor that can provide haptic feedback for surgeons using laparoscopic tools or for use in robotic grippers as part of robotic surgical systems. The technology is inspired by the surface of the lotus leaf, which is extremely sensitive to the pressure exerted by tiny drops of water and will repel them.
European Pharmaceutical Review
SEPTEMBER 14, 2023
A new proposal , ‘Business in Europe: Framework for Income Taxation’ (BEFIT), from European Commission (EC) introduces a simpler, single set of rules to determine the tax base of groups of companies. According to the EC, the new rules could reduce tax compliance costs for businesses operating in the EU by up to 65 percent. National tax authorities will also be to determine more easily which taxes are rightly due.
Advertiser: ZoomInfo
One of the biggest challenges for any B2B marketer is understanding your prospects’ next move — who is most likely to buy and when. Without these insights, marketing campaigns can feel more like guesswork, with high investment and little return. We’re here to tell you there’s a better way. By tracking buyers’ digital footprints and online activity, such as website visits, product reviews, and spikes in content consumption, you can engage prospects with a message that really resonates.
PharmaTimes
SEPTEMBER 14, 2023
The report highlights steps needed to ensure future pandemics are handled effectively - News - PharmaTimes
Contrarian Sales Techniques
SEPTEMBER 14, 2023
The Universal Truth Have you ever heard someone say, "I could never be in sales!"? It’s a sentiment many echo. Admittedly, the idea of selling for a living isn’t everyone's cup of tea. However, whether you're in the boardroom or at a family dinner, life often throws curveballs that require a bit of sales finesse. And here's the kicker: if you can master the art of selling, in many ways, you’re set for life.
PharmaTimes
SEPTEMBER 14, 2023
The funding will reduce waiting lists and ease the demand on the NHS during Winter - News - PharmaTimes
Pharmaceutical Technology
SEPTEMBER 14, 2023
Astellas Pharma is submitting a planning application for the construction of a new drug production facility in Ireland.
Advertiser: ZoomInfo
In this eBook, we’ll run through real-world examples that show how RevOps teams can benefit from modern solutions for the access, management, and activation of their GTM data. Whether you need to improve lead response times, boost adoption of core tools, improve lead qualification, or target and automate your GTM motions, you’ll find examples of how revenue teams are solving some of the toughest problems in modern business.
Penrod
SEPTEMBER 14, 2023
Over the last few months, you’ve learned lots about our core values! We have one more in store for you: Growth. Our five Core Values are: Accountability Flexibility Growth Grit Teamwork We define Growth as “Deliberate pursuit of improvement both on the individual and team level. We are all equally responsible for growth.” We’ve seen our folks display Growth by: Taking on new responsibilities and owning their success Stepping outside their comfort zone to learn something new Requesting, giving, a
LEVO Health
SEPTEMBER 14, 2023
In a healthcare landscape that’s more diverse than ever, the concept of one-size-fits-all is increasingly outdated. Physicians and other healthcare providers (HCPs) come from various disciplines, each with unique preferences, requirements, and pain points. Savvy healthcare marketers must now focus on tailored strategies that speak directly to the specific needs and preferences of HCPs.
Legacy MEDSearch
SEPTEMBER 14, 2023
Beacon Biosignals is thrilled to announce the milestone achievement of FDA 510(k) Clearance for the Dreem 3S, an advanced wearable headband with integrated machine learning algorithms to capture electroencephalogram (EEG) data from the brain to monitor sleep architecture and aid in the diagnosis of disturbed sleep. FDA Clearance marks it as equivalent to in-lab polysomnography for the assessment of sleep staging.
Rep-Lite
SEPTEMBER 14, 2023
In today’s rapidly changing business landscape, adaptability and efficiency are paramount. One solution that has gained immense popularity is the use of contract employees. They bring a range of benefits to the table, and when you partner with Rep-Lite , these advantages become even more pronounced. In this blog, we explore the numerous benefits of contract employees and how Rep-Lite can help you leverage these advantages to enhance your workforce.
Advertiser: ZoomInfo
Consolidating your tech stack is an effective cost-saving measure that drives GTM efficiency and adds value to your enterprise. With a cohesive, integrated tech stack, your revenue teams can deliver an excellent customer experience that sets you up to win faster than your competitors.
Expert insights. Personalized for you.
264 
Let's personalize your content